Important: Formulation and dosage details

Formulation:

Tablets 500 micrograms, 2mg, 4mg

Dosage:

For chemotherapy-induced nausea and vomiting, by mouth, 8 to 16mg in the morning, or in 2 divided doses before 2pm to reduce sleep disturbance. 

Notes:

Most patients can either take the tablets as they are or dispersed in a little water prior to use off-label.

Important: Formulation and dosage details

Formulation:

Oral solution (as sodium phosphate) 2mg/5mL (s)

Dosage:

For chemotherapy-induced nausea and vomiting, by mouth, 8 to 16mg in the morning, or in 2 divided doses before 2pm to reduce sleep disturbance. 

Important: Formulation and dosage details

Formulation:

Injection 3·3mg/mL, 6·6mg/2mL

Dosage:

For chemotherapy-induced nausea and vomiting,  by intravenous injection, as monotherapy or with 5HT3 antagonist, 8 to 16mg daily. For post-operative nausea and vomiting, by intravenous injection, in resistant cases 8mg as a single dose.

Important: Formulation and dosage details

Formulation:

Tablets 1·5mg, 5mg, 10mg

Important: Formulation and dosage details

Formulation:

Oral liquid 10mg/5mL

Important: Formulation and dosage details

Formulation:

Injection 5mg/mL

Important: Formulation and dosage details

Formulation:

Injection 50 micrograms/mL, 100 micrograms/mL, 500 micrograms/mL (s)

Dosage:

Only for intractable nausea and vomiting in palliative care off-label.